Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Conditions:   Painful Diabetic Neuropathy;   Diabetic Neuropathy, Painful Interventions:   Genetic: Long-Term Follow-Up of Patients who Received VM202;   Drug: Long-Term Follow-Up of Patients who Received Placebo Sponsor:   Helixmith Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials